Ana Devesa MD, PhD , Philip M. Robson PhD , Busra Cangut MD, MS , Ravi Vazirani MD , Vittoria Vergani MD , Gina LaRocca MD , Angelica M. Romero-Daza MD , Steve Liao MD , Lévi-Dan Azoulay MD , Renata Pyzik MS, MA , Rima A. Fayad MPH , Adam Jacobi MD , Ronan Abgral MD, PhD , Adam S. Morgenthau MD , Marc A. Miller MD , Zahi A. Fayad PhD , Maria Giovanna Trivieri MD, PhD
{"title":"Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis","authors":"Ana Devesa MD, PhD , Philip M. Robson PhD , Busra Cangut MD, MS , Ravi Vazirani MD , Vittoria Vergani MD , Gina LaRocca MD , Angelica M. Romero-Daza MD , Steve Liao MD , Lévi-Dan Azoulay MD , Renata Pyzik MS, MA , Rima A. Fayad MPH , Adam Jacobi MD , Ronan Abgral MD, PhD , Adam S. Morgenthau MD , Marc A. Miller MD , Zahi A. Fayad PhD , Maria Giovanna Trivieri MD, PhD","doi":"10.1016/j.hrthm.2024.09.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET)/magnetic resonance (MR) can identify inflammation and fibrosis, which are high-risk features in cardiac sarcoidosis.</div></div><div><h3>Objective</h3><div>The purpose of this study was to evaluate whether the involvement of certain myocardial segments is associated with higher risk compared to others.</div></div><div><h3>Methods</h3><div>One hundred twenty-four patients with suspected clinical sarcoidosis underwent <sup>18</sup>F-FDG-PET/MR. Late gadolinium enhancement (LGE) and focal <sup>18</sup>F-FDG uptake were evaluated globally and in the 16 myocardial segments. Presence of LGE was defined when the percentage of LGE exceeded 5.7% globally (relative to myocardial volume) and in each myocardial segment. Patients were followed up for 5.5 years. Events were defined as ventricular arrhythmia (VA) (including sustained ventricular tachycardia, ventricular fibrillation, and appropriate implantable cardioverter-defibrillator discharge), heart failure hospitalization, or all-cause death.</div></div><div><h3>Results</h3><div>Mean age was 57.1 ± 8.9 years, and 39.5% were female. Twenty-two patients (17.6%) had an event during follow-up, and 9 (7.2%) presented with VA. LGE and <sup>18</sup>F-FDG uptake were more frequent in patients with than without events (36.4% vs 7.8%, <em>P</em> = .001). Presence of LGE and <sup>18</sup>F-FDG in the basal anterior segment were independent predictors for events after adjustment for left ventricular ejection fraction and relative enhanced volume (LGE: odds ratio [1.2–92.4], <em>P</em> = .034;<sup>18</sup>F-FDG: odds ratio 5.5 [1.1–27.5], <em>P</em> = .038). LGE presence in basal to mid-anterior, mid-anteroseptal, and basal to mid-inferoseptal segments was an independent predictor of VA. Presence of <sup>18</sup>F-FDG in basal to mid-anterior, mid-inferoseptal and mid-inferior segments was an independent predictor of VA.</div></div><div><h3>Conclusion</h3><div>Involvement of specific myocardial segments, particularly basal to mid-anterior and mid-septal segments, is associated with higher rates of events in patients with suspected cardiac sarcoidosis.</div></div>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":"22 6","pages":"Pages 1606-1614"},"PeriodicalIF":5.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1547527124033010","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/magnetic resonance (MR) can identify inflammation and fibrosis, which are high-risk features in cardiac sarcoidosis.
Objective
The purpose of this study was to evaluate whether the involvement of certain myocardial segments is associated with higher risk compared to others.
Methods
One hundred twenty-four patients with suspected clinical sarcoidosis underwent 18F-FDG-PET/MR. Late gadolinium enhancement (LGE) and focal 18F-FDG uptake were evaluated globally and in the 16 myocardial segments. Presence of LGE was defined when the percentage of LGE exceeded 5.7% globally (relative to myocardial volume) and in each myocardial segment. Patients were followed up for 5.5 years. Events were defined as ventricular arrhythmia (VA) (including sustained ventricular tachycardia, ventricular fibrillation, and appropriate implantable cardioverter-defibrillator discharge), heart failure hospitalization, or all-cause death.
Results
Mean age was 57.1 ± 8.9 years, and 39.5% were female. Twenty-two patients (17.6%) had an event during follow-up, and 9 (7.2%) presented with VA. LGE and 18F-FDG uptake were more frequent in patients with than without events (36.4% vs 7.8%, P = .001). Presence of LGE and 18F-FDG in the basal anterior segment were independent predictors for events after adjustment for left ventricular ejection fraction and relative enhanced volume (LGE: odds ratio [1.2–92.4], P = .034;18F-FDG: odds ratio 5.5 [1.1–27.5], P = .038). LGE presence in basal to mid-anterior, mid-anteroseptal, and basal to mid-inferoseptal segments was an independent predictor of VA. Presence of 18F-FDG in basal to mid-anterior, mid-inferoseptal and mid-inferior segments was an independent predictor of VA.
Conclusion
Involvement of specific myocardial segments, particularly basal to mid-anterior and mid-septal segments, is associated with higher rates of events in patients with suspected cardiac sarcoidosis.
期刊介绍:
HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability.
HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community.
The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.